Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

5.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.6K
Cells of the Epidermis01:24

Cells of the Epidermis

6.4K
The epidermis is made of four or five layers of epithelial cells, depending on its location in the body. From deep to superficial, these layers are the stratum basale, stratum spinosum, stratum granulosum, stratum lucidum, and stratum corneum.
The cells in all these layers except the stratum basale are called keratinocytes, a type of cell that manufactures and stores the protein keratin. The keratinocytes in the stratum corneum are dead and regularly slough away, being replaced by cells from...
6.4K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

3.1K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.1K
Desmosomes01:05

Desmosomes

6.7K
The term desmosome derives from the Greek words "desmo" and "soma" meaning "adhesion bodies." This structure was first observed during the late 1800s and described as small, dense nodules in the epidermis. Desmosomes are button-like structures that help form an interlinked network of intermediate filaments across the cells. These junctions are  essential to hold cells together under mechanical stress and to maintain tissue integrity. Desmosomes are multi-protein...
6.7K
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

2.8K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.8K
Layers of the Epidermis01:21

Layers of the Epidermis

7.3K
The epidermis, the outermost layer of the skin, is composed of several distinct layers. From deep to superficial, the layers of the epidermis are as follows:
Stratum Basale
Stratum basale, also known as the stratum germinativum, is the deepest layer of the epidermis. It is composed of a single layer of actively dividing cells called basal cells or basal keratinocytes. These cells constantly undergo cell division to replenish the upper layers of the epidermis. Additionally, melanocytes, which...
7.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ASPRV1<sup>R208M</sup> in a patient with a nonsyndromic epidermal differentiation disorder/ichthyosis.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same author

In-depth Human Phenotype Ontology Curation Boosts Prioritization Performance for Netherton Syndrome.

The British journal of dermatology·2026
Same author

Cutaneous dysbiosis in inherited ichthyoses/epidermal differentiation disorders: a prospective case-control study.

The Journal of investigative dermatology·2026
Same author

Darier disease-A review highlighting new insights from the Darier Disease International Task Force.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Efficacy of subgingival irrigation with chemical agents as adjuvants to non-surgical periodontal therapy: systematic review and meta-analysis.

Clinical oral investigations·2026
Same author

Health-related quality of life in recessive dystrophic epidermolysis bullosa: findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES).

Orphanet journal of rare diseases·2026
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Buruli ulcer in Africa: between innovation and pragmatism.

Nature reviews. Disease primers·2026
Same journal

Author Correction: Atopic dermatitis.

Nature reviews. Disease primers·2026
See all related articles

Related Experiment Video

Updated: Dec 7, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.8K

Epidermolysis bullosa.

Ajoy Bardhan1,2, Leena Bruckner-Tuderman3, Iain L C Chapple4,5

  • 1Institute of Clinical Sciences, University of Birmingham, Edgbaston, Birmingham, UK. a.bardhan@bham.ac.uk.

Nature Reviews. Disease Primers
|September 25, 2020
PubMed
Summary
This summary is machine-generated.

Epidermolysis bullosa (EB) is a rare genetic skin disorder causing fragile skin and blisters. Advances in gene therapy offer hope for treating this condition and its complications.

More Related Videos

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

926
Author Spotlight: A Multi-Depth Porcine Model for Comprehensive Study of Burn Injuries and Healing Processes
02:49

Author Spotlight: A Multi-Depth Porcine Model for Comprehensive Study of Burn Injuries and Healing Processes

Published on: February 23, 2024

1.7K

Related Experiment Videos

Last Updated: Dec 7, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.8K
A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

926
Author Spotlight: A Multi-Depth Porcine Model for Comprehensive Study of Burn Injuries and Healing Processes
02:49

Author Spotlight: A Multi-Depth Porcine Model for Comprehensive Study of Burn Injuries and Healing Processes

Published on: February 23, 2024

1.7K

Area of Science:

  • Dermatology
  • Genetics
  • Molecular Biology

Background:

  • Epidermolysis bullosa (EB) comprises over 30 rare genetic skin disorders characterized by extreme skin fragility and blister formation.
  • These conditions present a wide phenotypic spectrum, including severe extracutaneous manifestations, significant morbidity, and mortality.
  • EB is classified into four major types based on cleavage plane and underlying molecular defects: EB simplex, junctional EB, dystrophic EB, and Kindler EB.

Purpose of the Study:

  • To provide a comprehensive overview of Epidermolysis Bullosa (EB), encompassing its genetic basis, clinical spectrum, diagnostic approaches, and current management strategies.
  • To highlight the significant advancements in understanding cutaneous biology driven by EB research.
  • To discuss emerging therapeutic avenues, including gene therapy, for EB.

Main Methods:

  • Diagnosis relies on correlating clinical findings, electron microscopy, and immunohistological features with genetic mutational analyses.
  • Research involves identifying pathogenetic mutations in genes responsible for cellular integrity and adhesion.
  • Preclinical studies focus on cell-based, protein replacement, and gene therapies.

Main Results:

  • Mutations in 16 distinct genes have been identified, affecting proteins crucial for skin integrity and adhesion.
  • Multidisciplinary care focuses on preventing blister formation, wound management, symptom alleviation, and addressing complications like squamous cell carcinoma.
  • Emerging preclinical therapies, including gene correction, show promise for future clinical application.

Conclusions:

  • Epidermolysis bullosa is a complex group of genetic disorders requiring precise diagnosis and multidisciplinary management.
  • While curative treatments are lacking, ongoing research in gene and cell-based therapies offers significant hope for patients.
  • Understanding the molecular basis of EB continues to advance cutaneous biology and therapeutic strategies.